Skip to content
PeptideAgent

Compounding pharmacies in Florida

By the PeptideAgent Editorial Team. Draft, pending editorial review.  Last verified

The Florida Board of Pharmacy (Florida Department of Health) regulates compounding pharmacies in Florida. Compounded GLP-1 limited. How to check a pharmacy's license, plus verified listings.

Florida at a glance

503A framework
Follows the federal 503A framework
Telehealth prescribing
Regulatory: Telehealth allowed
Asynchronous prescribing
Regulatory: Async allowed
Compounded GLP-1 access
Regulatory: Compounded GLP-1 limited

Verified compounding pharmacies serving Florida

No verified compounding pharmacies serving Florida are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.

Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.

Run a pharmacy, clinic, or telehealth service? Apply for a listing.

Who regulates compounding pharmacies in Florida

The Board of Pharmacy regulates compounding through chapter 465 (Pharmacy) and rule chapter 64B16-27, including rule 64B16-27.700 (definition of compounding) and rule 64B16-27.797 (standards of practice for sterile compounding). Florida has no separate state bulks list; eligibility of a peptide for compounding follows the federal 503A framework (approved drug component, USP or NF monograph, or FDA 503A bulks list). Two Florida-specific requirements matter for peptide patients: any out-of-state pharmacy that ships a dispensed drug to a Florida patient must register as a nonresident pharmacy under section 465.0156, and any pharmacy or outsourcing facility shipping a compounded sterile product (which covers injectable peptides) into Florida must also hold a nonresident sterile compounding permit under section 465.0158. A telehealth prescription filled by an unregistered mail-order pharmacy is being dispensed unlawfully in Florida even if the prescriber is compliant. [1] [2] [3] [4] [5] [6] [9]

Compounded GLP-1 access in Florida

Compounded semaglutide and tirzepatide are limited to the federal exception for documented patient specific needs because the FDA shortage allowances ended in 2025. Florida patients using telehealth GLP-1 programs should confirm the dispensing pharmacy appears in the Department of Health license lookup as a Florida pharmacy or a registered nonresident pharmacy with a sterile compounding permit. [1] [4] [12]

Research use only sellers in Florida

The Florida Drug and Cosmetic Act (chapter 499) prohibits manufacturing, distributing, or selling adulterated, misbranded, or unapproved new drugs in the state (section 499.005), and requires a Florida drug wholesale or manufacturer permit for anyone distributing prescription drugs. Sellers of "research use only" peptides shipped to Florida consumers for injection are not permitted under chapter 499 and are also subject to federal enforcement. [7] [8] [13]

How to check a compounding pharmacy in Florida

  1. Search the Florida Board of Pharmacy (Florida Department of Health) license lookup for the pharmacy by name. A pharmacy based elsewhere needs whatever license or registration Florida requires before it ships to you. [1] [2] [3] [4] [5] [6] [9]
  2. Ask whether it operates as a 503A pharmacy or a 503B outsourcing facility, and confirm a 503B claim against FDA's outsourcing facility information (see the verification checklist).
  3. Confirm the peptide can be lawfully compounded: check its status on the regulatory tracker or its peptide page before paying.
  4. Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Florida. [7] [8] [13]

Common questions in Florida

Is compounded semaglutide or tirzepatide still available in Florida?

Only in limited, patient specific cases. The federal shortage allowances ended in 2025, so a Florida pharmacy can compound a GLP-1 only when the approved product cannot meet a documented need. Any compounded injectable shipped into Florida must also come from a pharmacy holding a Florida nonresident sterile compounding permit. [4] [12]

How do I check whether a pharmacy is allowed to ship compounded peptides to Florida?

Search the Florida Department of Health license verification for the pharmacy name. An out-of-state pharmacy needs a nonresident pharmacy registration (section 465.0156), and if it ships sterile compounded products such as injectable peptides it also needs a nonresident sterile compounding permit (section 465.0158). If neither appears, the shipment is not lawful in Florida. [1] [3] [4]

Can a Florida pharmacy compound BPC-157 or other unapproved peptides?

No, not from bulk today. BPC-157 is not on the 503A bulks list. PCAC's July 2026 recommendation is advisory, and until FDA publishes a final rule a 503A pharmacy has no federal basis to compound it from bulk. State boards cannot authorize what federal law does not. Peptides still in FDA Category 2 cannot be compounded either. [5] [10] [11]

All peptide legal questions for Florida

Sources

  1. [1]Florida Board of Pharmacy (Florida Department of Health)
  2. [2]Florida Statutes chapter 465, Pharmacy
  3. [3]Florida Statutes section 465.0156, Registration of nonresident pharmacies
  4. [4]Florida Statutes section 465.0158, Nonresident sterile compounding permit
  5. [5]Florida Administrative Code rule 64B16-27.700, Definition of compounding
  6. [6]Florida Administrative Code rule 64B16-27.797, Standards of practice for compounding sterile preparations
  7. [7]Florida Statutes chapter 499, Florida Drug and Cosmetic Act
  8. [8]Florida Statutes section 499.005, Prohibited acts
  9. [9]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
  10. [10]FDA: Certain bulk drug substances for use in compounding may present significant safety risks (503A and 503B category lists)FDA